StockData
AbbVie Inc. logo

AbbVie Inc.

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$288.84−6.05 (-2.05%)

Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%

AbbVie Wholesaler Chargebacks — Payments by Year

Wholesaler Chargebacks — Payments ($M) ($M)

AbbVie Wholesaler Chargebacks — Payments: $17,482M in FY2025, up 18.1% from a year earlier. That is the highest of the 13 years on record here.

Latest, FY2025
17,482
Period ended Dec 31, 2025
Change on a year earlier
+18.1%
14,797 in FY2024
History
13 years
Since FY2013
Sources
11
Documents cited below

Where the FY2025 figure comes from

“|| Payments | (21,250) | (22,487) | (17,482)”

Source: Form 10-K (abbv-20251231.htm, filed 2026-02-20) ↗

Reported in Form 10-K Item 7 MD&A Rebates & Chargebacks Rollforward.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). AbbVie Wholesaler Chargebacks — Payments ($M), annual FY2013–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/gtn-chargebacks-paid

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.